Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of RYR2 mRNA | affects expression | 17562736
|
D000255 |
Adenosine Triphosphate |
Caffeine promotes the reaction [RYR2 protein results in increased secretion of Adenosine Triphosphate] | increases reaction|increases secretion | 18446524
|
D002110 |
Caffeine |
Caffeine promotes the reaction [RYR2 protein results in increased abundance of Calcium] | increases abundance|increases reaction | 18446524
|
D002110 |
Caffeine |
Caffeine promotes the reaction [RYR2 protein results in increased secretion of Adenosine Triphosphate] | increases reaction|increases secretion | 18446524
|
D002110 |
Caffeine |
Caffeine results in increased activity of RYR2 protein | increases activity | 18446524
|
D002110 |
Caffeine |
Dantrolene inhibits the reaction [Caffeine promotes the reaction [RYR2 protein results in increased secretion of Calcium]] | decreases reaction|increases reaction|increases secretion | 12887973
|
D002110 |
Caffeine |
HOMER1 protein alternative form inhibits the reaction [Caffeine promotes the reaction [RYR2 protein results in increased secretion of Calcium]] | decreases reaction|increases reaction|increases secretion | 12887973
|
D002118 |
Calcium |
Caffeine promotes the reaction [RYR2 protein results in increased abundance of Calcium] | increases abundance|increases reaction | 18446524
|
D002118 |
Calcium |
Dantrolene inhibits the reaction [Caffeine promotes the reaction [RYR2 protein results in increased secretion of Calcium]] | decreases reaction|increases reaction|increases secretion | 12887973
|
D002118 |
Calcium |
HOMER1 protein alternative form inhibits the reaction [Caffeine promotes the reaction [RYR2 protein results in increased secretion of Calcium]] | decreases reaction|increases reaction|increases secretion | 12887973
|
D002118 |
Calcium |
HOMER1 protein alternative form inhibits the reaction [Cyclic ADP-Ribose promotes the reaction [RYR2 protein results in increased secretion of Calcium]] | decreases reaction|increases reaction|increases secretion | 12887973
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in increased expression of RYR2 protein | increases expression | 16309888
|
D036563 |
Cyclic ADP-Ribose |
HOMER1 protein alternative form inhibits the reaction [Cyclic ADP-Ribose promotes the reaction [RYR2 protein results in increased secretion of Calcium]] | decreases reaction|increases reaction|increases secretion | 12887973
|
D003620 |
Dantrolene |
Dantrolene inhibits the reaction [Caffeine promotes the reaction [RYR2 protein results in increased secretion of Calcium]] | decreases reaction|increases reaction|increases secretion | 12887973
|
D004317 |
Doxorubicin |
Doxorubicin inhibits the reaction [Ryanodine binds to RYR2 protein] | affects binding|decreases reaction | 16244372
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of RYR2 mRNA | decreases expression | 16244372
|
D004317 |
Doxorubicin |
Doxorubicin results in decreased expression of RYR2 protein | decreases expression | 16244372
|
D004958 |
Estradiol |
Estradiol results in decreased expression of RYR2 mRNA | decreases expression | 20068009
|
D012433 |
Ryanodine |
Doxorubicin inhibits the reaction [Ryanodine binds to RYR2 protein] | affects binding|decreases reaction | 16244372
|
C025643 |
vinclozolin |
vinclozolin affects the expression of RYR2 mRNA | affects expression | 19015723
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
4.60 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.60 | 11473722 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
4.70 | 21441931 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.06 | 10982225 |
MESH:D001008 |
Anxiety Disorders |
|
vinclozolin |
3.75 | 19015723 |
OMIM:600996 |
ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA, FAMILIAL, 2 |
marker/mechanism |
|
| |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
4.92 | 14601052 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
3.94 | 17150277 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
2.26 | 18382427 16322301 18695136 15993339 18628466 17369602 15136595 16115903 15939500 17426702 16935488 18234424 16264153 15567936 11325840 15668708 16826403 15634643 15692762 16595493 17983394 16096432 15994142 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.26 | 17289903 16675129 12948864 17018787 17261762 14630087 18497071 19861407 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.66 | 16111702 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
5.03 | 16051944 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
4.68 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
4.68 | 16234567 17876044 18059187 16023760 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
4.68 | 16924424 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
3.22 | 16201981 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
2.67 | 6189445 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
3.62 | 17382496 17519947 16731534 16364871 17974986 16278810 15792986 16455267 16109756 16242529 18627295 17928571 17308081 15811867 17351982 16952015 16651473 17131338 17924179 16612575 15476868 17007740 16269455 15505089 17329180 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
2.98 | 16243910 17334414 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
8.04 | 10977129 |
MESH:D002386 |
Cataract |
|
Adenosine Triphosphate |
8.04 | 15003327 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.86 | 18566989 |
MESH:D002659 |
Child Development Disorders, Pervasive |
marker/mechanism |
|
| 21151189 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
2.14 | 18259882 18802399 |
MESH:D003456 |
Cryptorchidism |
|
vinclozolin |
4.50 | 14966744 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.54 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
6.59 | 19164858 11287661 19085960 19739265 19370779 12153990 14550746 11461765 17562736 16177239 19923254 12705907 14986274 18713872 12594235 14725611 16109766 16781746 16081117 18071297 19420014 11743745 2444490 17522070 15619225 11739529 16393943 17906064 10663392 12540782 16227642 15968718 11529661 10915739 16485898 11421492 10774834 19416960 12392966 12958197 11834606 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
6.59 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
6.59 | 17416283 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.32 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
3.77 | 18602426 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
7.83 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.83 | 19148513 18566989 11473722 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
5.37 | 18037988 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
4.78 | 19069698 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.89 | 16983495 |
MESH:D030342 |
Genetic Diseases, Inborn |
|
vinclozolin |
5.13 | 16973722 |
MESH:D005832 |
Genital Diseases, Male |
|
vinclozolin |
5.52 | 16417039 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
3.43 | 17150277 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
3.62 | 15692506 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
3.58 | 16879835 16330681 16244372 17888722 18006777 18674790 17875725 16707910 16495754 16144979 14766674 12587719 16244371 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
3.42 | 17481944 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
4.04 | 15692506 |
MESH:D006505 |
Hepatitis |
|
Caffeine |
5.14 | 11394713 |
MESH:D006521 |
Hepatitis, Chronic |
|
Dantrolene |
6.88 | 14986274 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.25 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
3.53 | 15147373 17606976 18501091 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.97 | 17088409 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.81 | 16870215 |
MESH:D007248 |
Infertility, Male |
|
vinclozolin |
3.13 | 16467254 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.05 | 16393666 16627594 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
10.52 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
10.52 | 16775033 15699352 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
10.52 | 15618244 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
4.29 | 16707910 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.09 | 15610895 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Calcium |
5.26 | 16316344 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
5.37 | 16085563 |
MESH:D007984 |
Leydig Cell Tumor |
|
vinclozolin |
4.93 | 16417039 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
2.63 | 16595196 16439617 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.63 | 14659978 14716833 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.66 | 19014921 16611625 19784758 12969438 11587558 19460945 12587719 16610002 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.37 | 16871587 17185352 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
3.10 | 16842330 17085340 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
2.15 | 17418594 6189445 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
3.56 | 16098063 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
3.91 | 17654614 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
4.74 | 15621674 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
6.41 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.41 | 16891317 11807958 11408345 17203775 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.70 | 19453300 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
2.30 | 16827129 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.74 | 19513568 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
3.11 | 17638057 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
4.64 | 15792986 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.98 | 17415656 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
3.00 | 19429709 15857846 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.39 | 16810080 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
3.00 | 18259882 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.93 | 17289903 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.94 | 16636307 16899518 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
4.12 | 16889571 15640375 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
3.81 | 16427766 11399458 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
3.33 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
2.99 | 18514411 |
MESH:D010024 |
Osteoporosis |
|
Calcium |
3.86 | 17882678 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
4.23 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.25 | 19401270 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.50 | 16870215 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
5.37 | 17983394 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
5.37 | 17638057 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
vinclozolin |
4.09 | 19015723 18042343 18220299 |
MESH:D011469 |
Prostatic Diseases |
|
vinclozolin |
5.13 | 18220299 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.02 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
3.29 | 16888761 18437689 15749863 16729912 15897917 16868541 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.29 | 16740699 |
MESH:D011472 |
Prostatitis |
|
vinclozolin |
5.13 | 18629315 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
4.40 | 17922066 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
4.12 | 16767912 17710206 15675481 15625365 17203757 18313854 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
4.40 | 14601052 16326096 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.98 | 17846226 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
3.01 | 15692506 |
MESH:D012893 |
Sleep Disorders |
|
Caffeine |
5.51 | 19395429 |
MESH:D007319 |
Sleep Initiation and Maintenance Disorders |
|
Caffeine |
5.32 | 17225163 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
4.74 | 15625365 17203757 16767912 |
MESH:D017180 |
Tachycardia, Ventricular |
marker/mechanism |
|
| 18052993 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
3.47 | 17909728 16010429 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.90 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
2.81 | 17653716 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.12 | 10982225 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
4.40 | 17678736 16364871 17334414 17638931 |
OMIM:604772 |
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 |
marker/mechanism |
|
| |